Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy